PADB-logoUPdb - Urinary Peptidomics and Peak-maps detection method SELDI-IMAC30(Cu2+)

Methodm/z (average)MethodCE-time [min]Intensity (average)Disease associationDisease biomarkerSpeciesSampleRegulationLSSR linkExternal accMolecule synonymMolecule nameSequencePMID/DOI
SELDI-IMAC30 (Cu2+)3340 11.5active and inactive lupus nephritisactive lupus nephritishuman     17046860
SELDI-IMAC30 (Cu2+)3980 10.1active lupus nephritisactive lupus nephritishuman     17046860
SELDI-IMAC30 (Cu2+)5872 7.9BK virus infection mediated renal allograft nephropathy (BKVAN) human     17035609
SELDI-IMAC30 (Cu2+)11311 8.3BK virus infection mediated renal allograft nephropathy (BKVAN) human     17035609
SELDI-IMAC30 (Cu2+)11929 19.8BK virus infection mediated renal allograft nephropathy (BKVAN) human     17035609
SELDI-IMAC30 (Cu2+)12727 13.2BK virus infection mediated renal allograft nephropathy (BKVAN) human     17035609
SELDI-IMAC30 (Cu2+)13349 3.6BK virus infection mediated renal allograft nephropathy (BKVAN) human     17035609
SELDI-IMAC30 (Cu2+)23482 4.8BK virus infection mediated renal allograft nephropathy (BKVAN) human     17035609
SELDI-IMAC30 (Cu2+)1505.93 23.98upper gastrointestinal cancer humanFrequency % above threshold: 6.9      
SELDI-IMAC30 (Cu2+)1513.56 9.71upper gastrointestinal cancer humanFrequency % above threshold: 0.5      
SELDI-IMAC30 (Cu2+)1525.36 17.91upper gastrointestinal cancer humanFrequency % above threshold: 27.7      
SELDI-IMAC30 (Cu2+)1548.78 17.2upper gastrointestinal cancer humanFrequency % above threshold: 52      
SELDI-IMAC30 (Cu2+)1578.35 7.49upper gastrointestinal cancer humanFrequency % above threshold: 0.5      
SELDI-IMAC30 (Cu2+)1599.53 5.1upper gastrointestinal cancer humanFrequency % above threshold: 1.5      
SELDI-IMAC30 (Cu2+)1630.28 -0.66upper gastrointestinal cancer humanFrequency % above threshold: 0.5      
SELDI-IMAC30 (Cu2+)1686.52 5.88upper gastrointestinal cancer humanFrequency % above threshold: 11.4      
SELDI-IMAC30 (Cu2+)1727.82 12.02upper gastrointestinal cancer humanFrequency % above threshold: 56.9      
SELDI-IMAC30 (Cu2+)1749.71 12upper gastrointestinal cancer humanFrequency % above threshold: 47.5      
SELDI-IMAC30 (Cu2+)1761.01 3.31upper gastrointestinal cancer humanFrequency % above threshold: 0.5      
SELDI-IMAC30 (Cu2+)1771.51 9.11upper gastrointestinal cancer humanFrequency % above threshold: 16.8      
SELDI-IMAC30 (Cu2+)1792.3 5.7upper gastrointestinal cancer humanFrequency % above threshold: 2.5      
SELDI-IMAC30 (Cu2+)1797.05 5.95upper gastrointestinal cancer humanFrequency % above threshold: 3      
SELDI-IMAC30 (Cu2+)1805.58 1.92upper gastrointestinal cancer humanFrequency % above threshold: 0.5      
SELDI-IMAC30 (Cu2+)1820.48 3.98upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)1830.61 0.9upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)1836.65 2.49upper gastrointestinal cancer humanFrequency % above threshold: 0.5      
SELDI-IMAC30 (Cu2+)1858.88 1.94upper gastrointestinal cancer humanFrequency % above threshold: 5      
SELDI-IMAC30 (Cu2+)1889.95 2.37upper gastrointestinal cancer humanFrequency % above threshold: 12.9      
SELDI-IMAC30 (Cu2+)1912.34 2.3upper gastrointestinal cancer humanFrequency % above threshold: 2.5      
SELDI-IMAC30 (Cu2+)1935 1.88upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)1945.8 2.76upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)1973.89 6.9upper gastrointestinal cancer humanFrequency % above threshold: 18.8      
SELDI-IMAC30 (Cu2+)1984.87 2.93upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)1997.35 8.7upper gastrointestinal cancer humanFrequency % above threshold: 44.6      
SELDI-IMAC30 (Cu2+)2007.41 3.69upper gastrointestinal cancer humanFrequency % above threshold: 0.5      
SELDI-IMAC30 (Cu2+)2019.26 8.88upper gastrointestinal cancer humanFrequency % above threshold: 9.9      
SELDI-IMAC30 (Cu2+)2030.92 2.57upper gastrointestinal cancer humanFrequency % above threshold: 0.5      
SELDI-IMAC30 (Cu2+)2046.07 2.47upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)2099.69 2.07upper gastrointestinal cancer humanFrequency % above threshold: 10.4      
SELDI-IMAC30 (Cu2+)2199.29 31.6upper gastrointestinal cancer humanFrequency % above threshold: 87.1      
SELDI-IMAC30 (Cu2+)2209.95 13.19upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)2219.81 10.31upper gastrointestinal cancer humanFrequency % above threshold: 2      
SELDI-IMAC30 (Cu2+)2244.24 4.27upper gastrointestinal cancer humanFrequency % above threshold: 1.5      
SELDI-IMAC30 (Cu2+)2252.49 2.01upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)2270.59 2.91upper gastrointestinal cancer humanFrequency % above threshold: 7.4      
SELDI-IMAC30 (Cu2+)2315.23 1.55upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)2325.9 1.85upper gastrointestinal cancer humanFrequency % above threshold: 6.4      
SELDI-IMAC30 (Cu2+)2346 4.24upper gastrointestinal cancer humanFrequency % above threshold: 20.3      
SELDI-IMAC30 (Cu2+)2364.09 0.91upper gastrointestinal cancer humanFrequency % above threshold: 2      
SELDI-IMAC30 (Cu2+)2382.55 17.64upper gastrointestinal cancer humanFrequency % above threshold: 77.7      
SELDI-IMAC30 (Cu2+)2396.81 4.54upper gastrointestinal cancer humanFrequency % above threshold: 0.5      
SELDI-IMAC30 (Cu2+)2444.47 63.49upper gastrointestinal cancer humanFrequency % above threshold: 87.1      
SELDI-IMAC30 (Cu2+)2457.94 28.29upper gastrointestinal cancer humanFrequency % above threshold: 2      
SELDI-IMAC30 (Cu2+)2469.17 14.34upper gastrointestinal cancer humanFrequency % above threshold: 0.5      
SELDI-IMAC30 (Cu2+)2475.65 8.43upper gastrointestinal cancer humanFrequency % above threshold: 1.5      
SELDI-IMAC30 (Cu2+)2487.95 7.85upper gastrointestinal cancer humanFrequency % above threshold: 5.5      
SELDI-IMAC30 (Cu2+)2546.22 4.04upper gastrointestinal cancer humanFrequency % above threshold: 16.8      
SELDI-IMAC30 (Cu2+)2578.21 10.95upper gastrointestinal cancer humanFrequency % above threshold: 55      
SELDI-IMAC30 (Cu2+)2595.87 4.4upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)2635.45 1.38upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)2668.07 12.44upper gastrointestinal cancer humanFrequency % above threshold: 80.2      
SELDI-IMAC30 (Cu2+)2700.27 4.74upper gastrointestinal cancer humanFrequency % above threshold: 7.4      
SELDI-IMAC30 (Cu2+)2718.37 1.48upper gastrointestinal cancer humanFrequency % above threshold: 0.5      
SELDI-IMAC30 (Cu2+)2744.42 1.84upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)2758.32 4.25upper gastrointestinal cancer humanFrequency % above threshold: 3.5      
SELDI-IMAC30 (Cu2+)2778.01 4.59upper gastrointestinal cancer humanFrequency % above threshold: 2.5      
SELDI-IMAC30 (Cu2+)2799.82 92.39upper gastrointestinal cancer humanFrequency % above threshold: 93.1      
SELDI-IMAC30 (Cu2+)2831.34 10.92upper gastrointestinal cancer humanFrequency % above threshold: 0.5      
SELDI-IMAC30 (Cu2+)2915.81 1.79upper gastrointestinal cancer humanFrequency % above threshold: 0.5      
SELDI-IMAC30 (Cu2+)2924.25 1.31upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)2949.81 5.23upper gastrointestinal cancer humanFrequency % above threshold: 33.7      
SELDI-IMAC30 (Cu2+)3011.31 10.6upper gastrointestinal cancer humanFrequency % above threshold: 65.4      
SELDI-IMAC30 (Cu2+)3044.34 3.02upper gastrointestinal cancer humanFrequency % above threshold: 0.5      
SELDI-IMAC30 (Cu2+)3094.06 3.99upper gastrointestinal cancer humanFrequency % above threshold: 28.7      
SELDI-IMAC30 (Cu2+)3108.04 2.23upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)3149.19 1.53upper gastrointestinal cancer humanFrequency % above threshold: 4      
SELDI-IMAC30 (Cu2+)3176.83 1.82upper gastrointestinal cancer humanFrequency % above threshold: 5.9      
SELDI-IMAC30 (Cu2+)3190.47 1.51upper gastrointestinal cancer humanFrequency % above threshold: 1.5      
SELDI-IMAC30 (Cu2+)3212.49 1.88upper gastrointestinal cancer humanFrequency % above threshold: 3      
SELDI-IMAC30 (Cu2+)3229.18 3.11upper gastrointestinal cancer humanFrequency % above threshold: 16.3      
SELDI-IMAC30 (Cu2+)3244.04 1.79upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)3272.52 1.22upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)3290.91 1.82upper gastrointestinal cancer humanFrequency % above threshold: 9.9      
SELDI-IMAC30 (Cu2+)3309.88 1.55upper gastrointestinal cancer humanFrequency % above threshold: 3.5      
SELDI-IMAC30 (Cu2+)3335.58 1.59upper gastrointestinal cancer humanFrequency % above threshold: 1.5      
SELDI-IMAC30 (Cu2+)3374.43 22.09upper gastrointestinal cancer humanFrequency % above threshold: 57.4      
SELDI-IMAC30 (Cu2+)3411.51 4.64upper gastrointestinal cancer humanFrequency % above threshold: 2      
SELDI-IMAC30 (Cu2+)3440.72 13.59upper gastrointestinal cancer humanFrequency % above threshold: 2.5      
SELDI-IMAC30 (Cu2+)3458.39 31.29upper gastrointestinal cancer humanFrequency % above threshold: 73.8      
SELDI-IMAC30 (Cu2+)3497.89 16.04upper gastrointestinal cancer humanFrequency % above threshold: 34.2      
SELDI-IMAC30 (Cu2+)3515.38 6.15upper gastrointestinal cancer humanFrequency % above threshold: 1.5      
SELDI-IMAC30 (Cu2+)3532.26 5.15upper gastrointestinal cancer humanFrequency % above threshold: 11.9      
SELDI-IMAC30 (Cu2+)3560.38 4.84upper gastrointestinal cancer humanFrequency % above threshold: 9.4      
SELDI-IMAC30 (Cu2+)3573.29 4.34upper gastrointestinal cancer humanFrequency % above threshold: 0.5      
SELDI-IMAC30 (Cu2+)3599.64 8.16upper gastrointestinal cancer humanFrequency % above threshold: 37.6      
SELDI-IMAC30 (Cu2+)3640.96 3.23upper gastrointestinal cancer humanFrequency % above threshold: 7.4      
SELDI-IMAC30 (Cu2+)3665.63 3.96upper gastrointestinal cancer humanFrequency % above threshold: 12.9      
SELDI-IMAC30 (Cu2+)3700.48 7.62upper gastrointestinal cancer humanFrequency % above threshold: 2.5      
SELDI-IMAC30 (Cu2+)3717.73 19.99upper gastrointestinal cancer humanFrequency % above threshold: 56.9      
SELDI-IMAC30 (Cu2+)3742.72 5.2upper gastrointestinal cancer humanFrequency % above threshold: 12.4      
SELDI-IMAC30 (Cu2+)3760.12 3.07upper gastrointestinal cancer humanFrequency % above threshold: 1.5      
SELDI-IMAC30 (Cu2+)3786.99 1.93upper gastrointestinal cancer humanFrequency % above threshold: 2      
SELDI-IMAC30 (Cu2+)3814.73 2.94upper gastrointestinal cancer humanFrequency % above threshold: 6.9      
SELDI-IMAC30 (Cu2+)3840.34 3.99upper gastrointestinal cancer humanFrequency % above threshold: 19.3      
SELDI-IMAC30 (Cu2+)3875.99 3.52upper gastrointestinal cancer humanFrequency % above threshold: 6.9      
SELDI-IMAC30 (Cu2+)3919.54 7.49upper gastrointestinal cancer humanFrequency % above threshold: 46.5      
SELDI-IMAC30 (Cu2+)3960.03 2.89upper gastrointestinal cancer humanFrequency % above threshold: 2      
SELDI-IMAC30 (Cu2+)3976.23 1.33upper gastrointestinal cancer humanFrequency % above threshold: 0.5      
SELDI-IMAC30 (Cu2+)4023.33 9.37upper gastrointestinal cancer humanFrequency % above threshold: 69.8      
SELDI-IMAC30 (Cu2+)4068.58 3.93upper gastrointestinal cancer humanFrequency % above threshold: 12.9      
SELDI-IMAC30 (Cu2+)4134.4 4.67upper gastrointestinal cancer humanFrequency % above threshold: 17.3      
SELDI-IMAC30 (Cu2+)4156.66 2.62upper gastrointestinal cancer humanFrequency % above threshold: 1.5      
SELDI-IMAC30 (Cu2+)4175.8 1.99upper gastrointestinal cancer humanFrequency % above threshold: 3      
SELDI-IMAC30 (Cu2+)4205.2 1.24upper gastrointestinal cancer humanFrequency % above threshold: 2      
SELDI-IMAC30 (Cu2+)4217.28 1.15upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)4254.67 5.87upper gastrointestinal cancer humanFrequency % above threshold: 17.3      
SELDI-IMAC30 (Cu2+)4296.29 1.24upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)4319.06 2.44upper gastrointestinal cancer humanFrequency % above threshold: 2.5      
SELDI-IMAC30 (Cu2+)4330.74 1.91upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)4354.09 2.68upper gastrointestinal cancer humanFrequency % above threshold: 0.5      
SELDI-IMAC30 (Cu2+)4375.95 13.58upper gastrointestinal cancer humanFrequency % above threshold: 53.5      
SELDI-IMAC30 (Cu2+)4395.62 3.85upper gastrointestinal cancer humanFrequency % above threshold: 0.5      
SELDI-IMAC30 (Cu2+)4435.85 2.16upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)4448.03 1.77upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)4464.86 1.73upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)4487.72 10.86upper gastrointestinal cancer humanFrequency % above threshold: 30.2      
SELDI-IMAC30 (Cu2+)4506.53 4.99upper gastrointestinal cancer humanFrequency % above threshold: 0.5      
SELDI-IMAC30 (Cu2+)4548.88 32.81upper gastrointestinal cancer humanFrequency % above threshold: 79.2      
SELDI-IMAC30 (Cu2+)4583.4 9.21upper gastrointestinal cancer humanFrequency % above threshold: 6.9      
SELDI-IMAC30 (Cu2+)4641.17 36.47upper gastrointestinal cancer humanFrequency % above threshold: 82.2      
SELDI-IMAC30 (Cu2+)4695.78 11.14upper gastrointestinal cancer humanFrequency % above threshold: 5      
SELDI-IMAC30 (Cu2+)4709.59 11.46upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)4762.56 350.57upper gastrointestinal cancer humanFrequency % above threshold: 99.5      
SELDI-IMAC30 (Cu2+)4824.86 24.4upper gastrointestinal cancer humanFrequency % above threshold: 2.5      
SELDI-IMAC30 (Cu2+)4847.69 15.45upper gastrointestinal cancer humanFrequency % above threshold: 4.5      
SELDI-IMAC30 (Cu2+)4869.78 9.08upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)4910.87 14.57upper gastrointestinal cancer humanFrequency % above threshold: 23.3      
SELDI-IMAC30 (Cu2+)4970.27 38.48upper gastrointestinal cancer humanFrequency % above threshold: 90.6      
SELDI-IMAC30 (Cu2+)5014.97 9.2upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)5072.51 34.47upper gastrointestinal cancer humanFrequency % above threshold: 40.6      
SELDI-IMAC30 (Cu2+)5113.79 8.34upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)5141.55 7.55upper gastrointestinal cancer humanFrequency % above threshold: 5.5      
SELDI-IMAC30 (Cu2+)5186.22 6.78upper gastrointestinal cancer humanFrequency % above threshold: 2      
SELDI-IMAC30 (Cu2+)5216.19 4.78upper gastrointestinal cancer humanFrequency % above threshold: 4.5      
SELDI-IMAC30 (Cu2+)5272 5.41upper gastrointestinal cancer humanFrequency % above threshold: 1.5      
SELDI-IMAC30 (Cu2+)5301.32 9.33upper gastrointestinal cancer humanFrequency % above threshold: 30.7      
SELDI-IMAC30 (Cu2+)5357.4 3.33upper gastrointestinal cancer humanFrequency % above threshold: 5.5      
SELDI-IMAC30 (Cu2+)5412.67 8.68upper gastrointestinal cancer humanFrequency % above threshold: 44.1      
SELDI-IMAC30 (Cu2+)5473.83 4.15upper gastrointestinal cancer humanFrequency % above threshold: 4.5      
SELDI-IMAC30 (Cu2+)5516.25 18.77upper gastrointestinal cancer humanFrequency % above threshold: 52      
SELDI-IMAC30 (Cu2+)5548.45 4.26upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)5585.44 4.16upper gastrointestinal cancer humanFrequency % above threshold: 5.5      
SELDI-IMAC30 (Cu2+)5643.5 5.66upper gastrointestinal cancer humanFrequency % above threshold: 27.7      
SELDI-IMAC30 (Cu2+)5709.96 4.82upper gastrointestinal cancer humanFrequency % above threshold: 22.3      
SELDI-IMAC30 (Cu2+)5757.31 3.19upper gastrointestinal cancer humanFrequency % above threshold: 10.9      
SELDI-IMAC30 (Cu2+)5816.94 14.86upper gastrointestinal cancer humanFrequency % above threshold: 67.8      
SELDI-IMAC30 (Cu2+)5847.3 4.3upper gastrointestinal cancer humanFrequency % above threshold: 7.9      
SELDI-IMAC30 (Cu2+)5890.56 3.51upper gastrointestinal cancer humanFrequency % above threshold: 9.9      
SELDI-IMAC30 (Cu2+)5957.73 2.54upper gastrointestinal cancer humanFrequency % above threshold: 9.4      
SELDI-IMAC30 (Cu2+)5983.51 2.12upper gastrointestinal cancer humanFrequency % above threshold: 3      
SELDI-IMAC30 (Cu2+)6079.85 2.26upper gastrointestinal cancer humanFrequency % above threshold: 8.9      
SELDI-IMAC30 (Cu2+)6142.32 1.84upper gastrointestinal cancer humanFrequency % above threshold: 0.5      
SELDI-IMAC30 (Cu2+)6159.77 2.13upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)6201.32 6.91upper gastrointestinal cancer humanFrequency % above threshold: 32.2      
SELDI-IMAC30 (Cu2+)6238.31 3.54upper gastrointestinal cancer humanFrequency % above threshold: 6.4      
SELDI-IMAC30 (Cu2+)6284.11 8.09upper gastrointestinal cancer humanFrequency % above threshold: 41.6      
SELDI-IMAC30 (Cu2+)6317.15 5.07upper gastrointestinal cancer humanFrequency % above threshold: 3      
SELDI-IMAC30 (Cu2+)6361.92 18.28upper gastrointestinal cancer humanFrequency % above threshold: 85.2      
SELDI-IMAC30 (Cu2+)6411.52 5.68upper gastrointestinal cancer humanFrequency % above threshold: 2.5      
SELDI-IMAC30 (Cu2+)6459.01 12.17upper gastrointestinal cancer humanFrequency % above threshold: 73.8      
SELDI-IMAC30 (Cu2+)6520.57 3.76upper gastrointestinal cancer humanFrequency % above threshold: 3      
SELDI-IMAC30 (Cu2+)6566.34 4.67upper gastrointestinal cancer humanFrequency % above threshold: 17.3      
SELDI-IMAC30 (Cu2+)6615.37 2.08upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)6673.93 3.2upper gastrointestinal cancer humanFrequency % above threshold: 25.3      
SELDI-IMAC30 (Cu2+)6758.31 1.38upper gastrointestinal cancer humanFrequency % above threshold: 2.5      
SELDI-IMAC30 (Cu2+)6806.92 2.5upper gastrointestinal cancer humanFrequency % above threshold: 22.8      
SELDI-IMAC30 (Cu2+)6886.87 1.81upper gastrointestinal cancer humanFrequency % above threshold: 11.9      
SELDI-IMAC30 (Cu2+)6919.35 1.31upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)6952.59 1.04upper gastrointestinal cancer humanFrequency % above threshold: 4      
SELDI-IMAC30 (Cu2+)7008.51 1.58upper gastrointestinal cancer humanFrequency % above threshold: 8.4      
SELDI-IMAC30 (Cu2+)7072.45 2.28upper gastrointestinal cancer humanFrequency % above threshold: 32.7      
SELDI-IMAC30 (Cu2+)7161.53 1.03upper gastrointestinal cancer humanFrequency % above threshold: 2      
SELDI-IMAC30 (Cu2+)7192.36 1.67upper gastrointestinal cancer humanFrequency % above threshold: 10.9      
SELDI-IMAC30 (Cu2+)7265.19 1.5upper gastrointestinal cancer humanFrequency % above threshold: 11.4      
SELDI-IMAC30 (Cu2+)7327.47 3.49upper gastrointestinal cancer humanFrequency % above threshold: 67.8      
SELDI-IMAC30 (Cu2+)7403.26 1.07upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)7439.73 2.09upper gastrointestinal cancer humanFrequency % above threshold: 1.5      
SELDI-IMAC30 (Cu2+)7478.81 7.6upper gastrointestinal cancer humanFrequency % above threshold: 74.3      
SELDI-IMAC30 (Cu2+)7521.12 2.95upper gastrointestinal cancer humanFrequency % above threshold: 2      
SELDI-IMAC30 (Cu2+)7555.46 3.09upper gastrointestinal cancer humanFrequency % above threshold: 24.3      
SELDI-IMAC30 (Cu2+)7601.89 1.83upper gastrointestinal cancer humanFrequency % above threshold: 2      
SELDI-IMAC30 (Cu2+)7634.38 3.18upper gastrointestinal cancer humanFrequency % above threshold: 0.5      
SELDI-IMAC30 (Cu2+)7685.2 18.07upper gastrointestinal cancer humanFrequency % above threshold: 85.6      
SELDI-IMAC30 (Cu2+)7766 9.07upper gastrointestinal cancer humanFrequency % above threshold: 70.3      
SELDI-IMAC30 (Cu2+)7804.65 4.67upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)7846.51 7.57upper gastrointestinal cancer humanFrequency % above threshold: 44.6      
SELDI-IMAC30 (Cu2+)7904.24 7.5upper gastrointestinal cancer humanFrequency % above threshold: 36.1      
SELDI-IMAC30 (Cu2+)7976.14 7.58upper gastrointestinal cancer humanFrequency % above threshold: 2.5      
SELDI-IMAC30 (Cu2+)8034.63 42.87upper gastrointestinal cancer humanFrequency % above threshold: 98      
SELDI-IMAC30 (Cu2+)8104.65 8.63upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)8137.76 7.05upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)8157.12 6.72upper gastrointestinal cancer humanFrequency % above threshold: 6.9      
SELDI-IMAC30 (Cu2+)8191.5 6.66upper gastrointestinal cancer humanFrequency % above threshold: 5.9      
SELDI-IMAC30 (Cu2+)8244.73 10.18upper gastrointestinal cancer humanFrequency % above threshold: 88.6      
SELDI-IMAC30 (Cu2+)8290.93 4.92upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)8314.01 4.13upper gastrointestinal cancer humanFrequency % above threshold: 2      
SELDI-IMAC30 (Cu2+)8370.05 3.18upper gastrointestinal cancer humanFrequency % above threshold: 1.5      
SELDI-IMAC30 (Cu2+)8399.15 3.31upper gastrointestinal cancer humanFrequency % above threshold: 4.5      
SELDI-IMAC30 (Cu2+)8465.81 2.84upper gastrointestinal cancer humanFrequency % above threshold: 13.4      
SELDI-IMAC30 (Cu2+)8524.89 2.41upper gastrointestinal cancer humanFrequency % above threshold: 1.5      
SELDI-IMAC30 (Cu2+)8605.85 1.47upper gastrointestinal cancer humanFrequency % above threshold: 5.9      
SELDI-IMAC30 (Cu2+)8655.45 2.12upper gastrointestinal cancer humanFrequency % above threshold: 8.4      
SELDI-IMAC30 (Cu2+)8699.07 1.27upper gastrointestinal cancer humanFrequency % above threshold: 2      
SELDI-IMAC30 (Cu2+)8731.04 0.91upper gastrointestinal cancer humanFrequency % above threshold: 1.5      
SELDI-IMAC30 (Cu2+)8813.27 0.61upper gastrointestinal cancer humanFrequency % above threshold: 1.5      
SELDI-IMAC30 (Cu2+)8891.99 1.15upper gastrointestinal cancer humanFrequency % above threshold: 15.4      
SELDI-IMAC30 (Cu2+)8947.51 0.7upper gastrointestinal cancer humanFrequency % above threshold: 0.5      
SELDI-IMAC30 (Cu2+)8969.57 0.62upper gastrointestinal cancer humanFrequency % above threshold: 0.5      
SELDI-IMAC30 (Cu2+)9000.44 0.73upper gastrointestinal cancer humanFrequency % above threshold: 0.5      
SELDI-IMAC30 (Cu2+)9021.36 0.7upper gastrointestinal cancer humanFrequency % above threshold: 0.5      
SELDI-IMAC30 (Cu2+)9052.27 1.01upper gastrointestinal cancer humanFrequency % above threshold: 0.5      
SELDI-IMAC30 (Cu2+)9114.83 4.13upper gastrointestinal cancer humanFrequency % above threshold: 34.7      
SELDI-IMAC30 (Cu2+)9188.64 5.94upper gastrointestinal cancer humanFrequency % above threshold: 55.9      
SELDI-IMAC30 (Cu2+)9270.08 2.83upper gastrointestinal cancer humanFrequency % above threshold: 14.4      
SELDI-IMAC30 (Cu2+)9337.85 4.49upper gastrointestinal cancer humanFrequency % above threshold: 68.8      
SELDI-IMAC30 (Cu2+)9382.71 2.33upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)9411.69 2.07upper gastrointestinal cancer humanFrequency % above threshold: 3.5      
SELDI-IMAC30 (Cu2+)9461.8 2.37upper gastrointestinal cancer humanFrequency % above threshold: 6.9      
SELDI-IMAC30 (Cu2+)9520.87 3.38upper gastrointestinal cancer humanFrequency % above threshold: 41.1      
SELDI-IMAC30 (Cu2+)9582.05 2.39upper gastrointestinal cancer humanFrequency % above threshold: 4      
SELDI-IMAC30 (Cu2+)9618.43 2.26upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)9671.55 4.21upper gastrointestinal cancer humanFrequency % above threshold: 32.2      
SELDI-IMAC30 (Cu2+)9738.65 4.52upper gastrointestinal cancer humanFrequency % above threshold: 1.5      
SELDI-IMAC30 (Cu2+)9788.21 10.27upper gastrointestinal cancer humanFrequency % above threshold: 38.1      
SELDI-IMAC30 (Cu2+)9846.59 14.2upper gastrointestinal cancer humanFrequency % above threshold: 53      
SELDI-IMAC30 (Cu2+)9891.23 10.55upper gastrointestinal cancer humanFrequency % above threshold: 35.6      
SELDI-IMAC30 (Cu2+)9967.58 6.96upper gastrointestinal cancer humanFrequency % above threshold: 27.2      
SELDI-IMAC30 (Cu2+)10063.57 6.88upper gastrointestinal cancer humanFrequency % above threshold: 32.7      
SELDI-IMAC30 (Cu2+)10161.57 4.37upper gastrointestinal cancer humanFrequency % above threshold: 6.4      
SELDI-IMAC30 (Cu2+)10225.99 3.81upper gastrointestinal cancer humanFrequency % above threshold: 24.3      
SELDI-IMAC30 (Cu2+)10271.43 3.01upper gastrointestinal cancer humanFrequency % above threshold: 3.5      
SELDI-IMAC30 (Cu2+)10327.75 2.54upper gastrointestinal cancer humanFrequency % above threshold: 3.5      
SELDI-IMAC30 (Cu2+)10398.87 2.28upper gastrointestinal cancer humanFrequency % above threshold: 6.9      
SELDI-IMAC30 (Cu2+)10466.88 2.42upper gastrointestinal cancer humanFrequency % above threshold: 12.9      
SELDI-IMAC30 (Cu2+)10549.62 1.75upper gastrointestinal cancer humanFrequency % above threshold: 8.4      
SELDI-IMAC30 (Cu2+)10606.53 1.5upper gastrointestinal cancer humanFrequency % above threshold: 6.9      
SELDI-IMAC30 (Cu2+)10681.65 1.47upper gastrointestinal cancer humanFrequency % above threshold: 8.4      
SELDI-IMAC30 (Cu2+)10732.44 1.2upper gastrointestinal cancer humanFrequency % above threshold: 4.5      
SELDI-IMAC30 (Cu2+)10796.57 1.76upper gastrointestinal cancer humanFrequency % above threshold: 10.4      
SELDI-IMAC30 (Cu2+)10880.22 5.72upper gastrointestinal cancer humanFrequency % above threshold: 22.8      
SELDI-IMAC30 (Cu2+)10974.6 1.38upper gastrointestinal cancer humanFrequency % above threshold: 3.5      
SELDI-IMAC30 (Cu2+)11013.7 1.16upper gastrointestinal cancer humanFrequency % above threshold: 2.5      
SELDI-IMAC30 (Cu2+)11093.7 2upper gastrointestinal cancer humanFrequency % above threshold: 22.3      
SELDI-IMAC30 (Cu2+)11215.27 1.24upper gastrointestinal cancer humanFrequency % above threshold: 15.4      
SELDI-IMAC30 (Cu2+)11264.73 1.03upper gastrointestinal cancer humanFrequency % above threshold: 3.5      
SELDI-IMAC30 (Cu2+)11362.78 1.74upper gastrointestinal cancer humanFrequency % above threshold: 20.8      
SELDI-IMAC30 (Cu2+)11429.94 1.07upper gastrointestinal cancer humanFrequency % above threshold: 5.9      
SELDI-IMAC30 (Cu2+)11466.11 0.8upper gastrointestinal cancer humanFrequency % above threshold: 1.5      
SELDI-IMAC30 (Cu2+)11533.25 1.3upper gastrointestinal cancer humanFrequency % above threshold: 6.9      
SELDI-IMAC30 (Cu2+)11593.92 0.98upper gastrointestinal cancer humanFrequency % above threshold: 1.5      
SELDI-IMAC30 (Cu2+)11668.94 2.46upper gastrointestinal cancer humanFrequency % above threshold: 5      
SELDI-IMAC30 (Cu2+)11760.47 11.54upper gastrointestinal cancer humanFrequency % above threshold: 87.1      
SELDI-IMAC30 (Cu2+)11882.46 2upper gastrointestinal cancer humanFrequency % above threshold: 6.9      
SELDI-IMAC30 (Cu2+)11979.32 2.66upper gastrointestinal cancer humanFrequency % above threshold: 54.5      
SELDI-IMAC30 (Cu2+)12109.11 0.88upper gastrointestinal cancer humanFrequency % above threshold: 7.4      
SELDI-IMAC30 (Cu2+)12194.66 0.94upper gastrointestinal cancer humanFrequency % above threshold: 11.9      
SELDI-IMAC30 (Cu2+)12267.96 0.79upper gastrointestinal cancer humanFrequency % above threshold: 5      
SELDI-IMAC30 (Cu2+)12344.12 0.68upper gastrointestinal cancer humanFrequency % above threshold: 2.5      
SELDI-IMAC30 (Cu2+)12381.61 0.82upper gastrointestinal cancer humanFrequency % above threshold: 3.5      
SELDI-IMAC30 (Cu2+)12424.39 0.89upper gastrointestinal cancer humanFrequency % above threshold: 15.4      
SELDI-IMAC30 (Cu2+)12519.86 1upper gastrointestinal cancer humanFrequency % above threshold: 10.9      
SELDI-IMAC30 (Cu2+)12609.88 0.57upper gastrointestinal cancer humanFrequency % above threshold: 0.5      
SELDI-IMAC30 (Cu2+)12641.87 0.59upper gastrointestinal cancer humanFrequency % above threshold: 2.5      
SELDI-IMAC30 (Cu2+)12677.52 0.69upper gastrointestinal cancer humanFrequency % above threshold: 3      
SELDI-IMAC30 (Cu2+)12726.15 1.21upper gastrointestinal cancer humanFrequency % above threshold: 11.9      
SELDI-IMAC30 (Cu2+)12800.06 1.52upper gastrointestinal cancer humanFrequency % above threshold: 55      
SELDI-IMAC30 (Cu2+)12938.5 0.61upper gastrointestinal cancer humanFrequency % above threshold: 5.9      
SELDI-IMAC30 (Cu2+)13013.49 0.65upper gastrointestinal cancer humanFrequency % above threshold: 11.4      
SELDI-IMAC30 (Cu2+)13071.73 0.45upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)13147.63 0.47upper gastrointestinal cancer humanFrequency % above threshold: 1.5      
SELDI-IMAC30 (Cu2+)13238.96 0.88upper gastrointestinal cancer humanFrequency % above threshold: 17.3      
SELDI-IMAC30 (Cu2+)13334.97 1.13upper gastrointestinal cancer humanFrequency % above threshold: 14.4      
SELDI-IMAC30 (Cu2+)13408.8 1.32upper gastrointestinal cancer humanFrequency % above threshold: 23.3      
SELDI-IMAC30 (Cu2+)13483.83 0.89upper gastrointestinal cancer humanFrequency % above threshold: 7.4      
SELDI-IMAC30 (Cu2+)13556.48 0.72upper gastrointestinal cancer humanFrequency % above threshold: 2.5      
SELDI-IMAC30 (Cu2+)13596.69 0.64upper gastrointestinal cancer humanFrequency % above threshold: 2      
SELDI-IMAC30 (Cu2+)13675.86 0.49upper gastrointestinal cancer humanFrequency % above threshold: 3      
SELDI-IMAC30 (Cu2+)13712.6 0.49upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)13760.52 0.62upper gastrointestinal cancer humanFrequency % above threshold: 14.4      
SELDI-IMAC30 (Cu2+)13827.33 0.56upper gastrointestinal cancer humanFrequency % above threshold: 10.9      
SELDI-IMAC30 (Cu2+)13917.9 0.59upper gastrointestinal cancer humanFrequency % above threshold: 22.3      
SELDI-IMAC30 (Cu2+)13997.4 0.38upper gastrointestinal cancer humanFrequency % above threshold: 2      
SELDI-IMAC30 (Cu2+)14045.19 0.42upper gastrointestinal cancer humanFrequency % above threshold: 3.5      
SELDI-IMAC30 (Cu2+)14139.8 0.66upper gastrointestinal cancer humanFrequency % above threshold: 43.6      
SELDI-IMAC30 (Cu2+)14254.49 0.22upper gastrointestinal cancer humanFrequency % above threshold: 2      
SELDI-IMAC30 (Cu2+)14314.08 0.23upper gastrointestinal cancer humanFrequency % above threshold: 2      
SELDI-IMAC30 (Cu2+)14377.21 0.24upper gastrointestinal cancer humanFrequency % above threshold: 5      
SELDI-IMAC30 (Cu2+)14438.38 0.22upper gastrointestinal cancer humanFrequency % above threshold: 2      
SELDI-IMAC30 (Cu2+)14480.05 0.22upper gastrointestinal cancer humanFrequency % above threshold: 3.5      
SELDI-IMAC30 (Cu2+)14578.41 0.43upper gastrointestinal cancer humanFrequency % above threshold: 27.7      
SELDI-IMAC30 (Cu2+)14662.48 0.24upper gastrointestinal cancer humanFrequency % above threshold: 2.5      
SELDI-IMAC30 (Cu2+)14720.22 0.23upper gastrointestinal cancer humanFrequency % above threshold: 5      
SELDI-IMAC30 (Cu2+)14763.37 0.19upper gastrointestinal cancer humanFrequency % above threshold: 3      
SELDI-IMAC30 (Cu2+)14835.2 0.24upper gastrointestinal cancer humanFrequency % above threshold: 3      
SELDI-IMAC30 (Cu2+)14919.97 0.71upper gastrointestinal cancer humanFrequency % above threshold: 6.4      
SELDI-IMAC30 (Cu2+)15001.37 0.32upper gastrointestinal cancer humanFrequency % above threshold: 11.9      
SELDI-IMAC30 (Cu2+)15125.79 0.4upper gastrointestinal cancer humanFrequency % above threshold: 11.4      
SELDI-IMAC30 (Cu2+)15224.27 0.67upper gastrointestinal cancer humanFrequency % above threshold: 8.9      
SELDI-IMAC30 (Cu2+)15334.1 0.6upper gastrointestinal cancer humanFrequency % above threshold: 33.7      
SELDI-IMAC30 (Cu2+)15438.74 0.45upper gastrointestinal cancer humanFrequency % above threshold: 9.9      
SELDI-IMAC30 (Cu2+)15564.61 0.48upper gastrointestinal cancer humanFrequency % above threshold: 27.2      
SELDI-IMAC30 (Cu2+)15703.57 0.26upper gastrointestinal cancer humanFrequency % above threshold: 2.5      
SELDI-IMAC30 (Cu2+)15776.55 0.27upper gastrointestinal cancer humanFrequency % above threshold: 3.5      
SELDI-IMAC30 (Cu2+)15895.52 0.31upper gastrointestinal cancer humanFrequency % above threshold: 16.3      
SELDI-IMAC30 (Cu2+)16106.21 0.41upper gastrointestinal cancer humanFrequency % above threshold: 32.7      
SELDI-IMAC30 (Cu2+)16258.11 0.22upper gastrointestinal cancer humanFrequency % above threshold: 4.5      
SELDI-IMAC30 (Cu2+)16412.04 0.3upper gastrointestinal cancer humanFrequency % above threshold: 9.4      
SELDI-IMAC30 (Cu2+)16533.56 0.2upper gastrointestinal cancer humanFrequency % above threshold: 5      
SELDI-IMAC30 (Cu2+)16643.06 0.21upper gastrointestinal cancer humanFrequency % above threshold: 10.9      
SELDI-IMAC30 (Cu2+)16739.51 0.16upper gastrointestinal cancer humanFrequency % above threshold: 5.5      
SELDI-IMAC30 (Cu2+)16826.02 0.15upper gastrointestinal cancer humanFrequency % above threshold: 4.5      
SELDI-IMAC30 (Cu2+)16975.9 0.18upper gastrointestinal cancer humanFrequency % above threshold: 19.3      
SELDI-IMAC30 (Cu2+)17201.01 0.12upper gastrointestinal cancer humanFrequency % above threshold: 3.5      
SELDI-IMAC30 (Cu2+)17290.77 0.12upper gastrointestinal cancer humanFrequency % above threshold: 10.4      
SELDI-IMAC30 (Cu2+)17362.7 0.11upper gastrointestinal cancer humanFrequency % above threshold: 6.4      
SELDI-IMAC30 (Cu2+)17447.55 0.11upper gastrointestinal cancer humanFrequency % above threshold: 4      
SELDI-IMAC30 (Cu2+)17569.26 0.12upper gastrointestinal cancer humanFrequency % above threshold: 12.4      
SELDI-IMAC30 (Cu2+)17658.8 0.1upper gastrointestinal cancer humanFrequency % above threshold: 5.5      
SELDI-IMAC30 (Cu2+)17730.62 0.1upper gastrointestinal cancer humanFrequency % above threshold: 2      
SELDI-IMAC30 (Cu2+)17856.42 0.09upper gastrointestinal cancer humanFrequency % above threshold: 2      
SELDI-IMAC30 (Cu2+)17972.77 0.11upper gastrointestinal cancer humanFrequency % above threshold: 10.9      
SELDI-IMAC30 (Cu2+)18176.68 0.17upper gastrointestinal cancer humanFrequency % above threshold: 40.6      
SELDI-IMAC30 (Cu2+)18330.85 0.1upper gastrointestinal cancer humanFrequency % above threshold: 4.5      
SELDI-IMAC30 (Cu2+)18428.37 0.09upper gastrointestinal cancer humanFrequency % above threshold: 5.5      
SELDI-IMAC30 (Cu2+)18651.46 0.06upper gastrointestinal cancer humanFrequency % above threshold: 2.5      
SELDI-IMAC30 (Cu2+)18757.16 0.09upper gastrointestinal cancer humanFrequency % above threshold: 4      
SELDI-IMAC30 (Cu2+)18880.16 0.1upper gastrointestinal cancer humanFrequency % above threshold: 18.3      
SELDI-IMAC30 (Cu2+)19008.51 0.13upper gastrointestinal cancer humanFrequency % above threshold: 7.4      
SELDI-IMAC30 (Cu2+)19133 0.14upper gastrointestinal cancer humanFrequency % above threshold: 22.3      
SELDI-IMAC30 (Cu2+)19267.69 0.09upper gastrointestinal cancer humanFrequency % above threshold: 1.5      
SELDI-IMAC30 (Cu2+)19351.45 0.13upper gastrointestinal cancer humanFrequency % above threshold: 5      
SELDI-IMAC30 (Cu2+)19734.96 0.23upper gastrointestinal cancer humanFrequency % above threshold: 69.8      
SELDI-IMAC30 (Cu2+)19933.23 0.34upper gastrointestinal cancer humanFrequency % above threshold: 3      
SELDI-IMAC30 (Cu2+)20045.08 0.32upper gastrointestinal cancer humanFrequency % above threshold: 3      
SELDI-IMAC30 (Cu2+)20231.76 0.27upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)20287.29 0.25upper gastrointestinal cancer humanFrequency % above threshold: 0.5      
SELDI-IMAC30 (Cu2+)20595.81 0.48upper gastrointestinal cancer humanFrequency % above threshold: 55      
SELDI-IMAC30 (Cu2+)20713.27 0.28upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)20827.3 0.28upper gastrointestinal cancer humanFrequency % above threshold: 3      
SELDI-IMAC30 (Cu2+)20998.91 0.33upper gastrointestinal cancer humanFrequency % above threshold: 2.5      
SELDI-IMAC30 (Cu2+)21249.07 0.44upper gastrointestinal cancer humanFrequency % above threshold: 27.7      
SELDI-IMAC30 (Cu2+)21502.51 0.39upper gastrointestinal cancer humanFrequency % above threshold: 2.5      
SELDI-IMAC30 (Cu2+)21551.38 0.38upper gastrointestinal cancer humanFrequency % above threshold: 1.5      
SELDI-IMAC30 (Cu2+)21608.66 0.39upper gastrointestinal cancer humanFrequency % above threshold: 1.5      
SELDI-IMAC30 (Cu2+)21808.27 0.46upper gastrointestinal cancer humanFrequency % above threshold: 19.3      
SELDI-IMAC30 (Cu2+)21985.46 0.41upper gastrointestinal cancer humanFrequency % above threshold: 3      
SELDI-IMAC30 (Cu2+)22056.48 0.38upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)22212.14 0.4upper gastrointestinal cancer humanFrequency % above threshold: 1.5      
SELDI-IMAC30 (Cu2+)22327.4 0.43upper gastrointestinal cancer humanFrequency % above threshold: 4.5      
SELDI-IMAC30 (Cu2+)22446.37 0.44upper gastrointestinal cancer humanFrequency % above threshold: 3      
SELDI-IMAC30 (Cu2+)22575.74 0.47upper gastrointestinal cancer humanFrequency % above threshold: 3      
SELDI-IMAC30 (Cu2+)22642.88 0.5upper gastrointestinal cancer humanFrequency % above threshold: 2      
SELDI-IMAC30 (Cu2+)22736.83 0.52upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)22838.74 0.57upper gastrointestinal cancer humanFrequency % above threshold: 2.5      
SELDI-IMAC30 (Cu2+)22933.82 0.61upper gastrointestinal cancer humanFrequency % above threshold: 1.5      
SELDI-IMAC30 (Cu2+)23072.76 0.66upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)23162.8 0.71upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)23510.26 1upper gastrointestinal cancer humanFrequency % above threshold: 38.1      
SELDI-IMAC30 (Cu2+)23806.69 0.94upper gastrointestinal cancer humanFrequency % above threshold: 12.4      
SELDI-IMAC30 (Cu2+)23965.51 0.9upper gastrointestinal cancer humanFrequency % above threshold: 1.5      
SELDI-IMAC30 (Cu2+)24146.56 1.03upper gastrointestinal cancer humanFrequency % above threshold: 28.2      
SELDI-IMAC30 (Cu2+)24385.46 1.04upper gastrointestinal cancer humanFrequency % above threshold: 35.2      
SELDI-IMAC30 (Cu2+)24608.55 1upper gastrointestinal cancer humanFrequency % above threshold: 36.1      
SELDI-IMAC30 (Cu2+)24787.74 0.78upper gastrointestinal cancer humanFrequency % above threshold: 1.5      
SELDI-IMAC30 (Cu2+)24958.24 0.65upper gastrointestinal cancer humanFrequency % above threshold: 3      
SELDI-IMAC30 (Cu2+)25060.14 0.62upper gastrointestinal cancer humanFrequency % above threshold: 3.5      
SELDI-IMAC30 (Cu2+)25143.54 0.57upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)25212.82 0.55upper gastrointestinal cancer humanFrequency % above threshold: 2      
SELDI-IMAC30 (Cu2+)25391.16 0.48upper gastrointestinal cancer humanFrequency % above threshold: 0.5      
SELDI-IMAC30 (Cu2+)25620.74 0.43upper gastrointestinal cancer humanFrequency % above threshold: 6.4      
SELDI-IMAC30 (Cu2+)25937.55 0.3upper gastrointestinal cancer humanFrequency % above threshold: 2      
SELDI-IMAC30 (Cu2+)26076.16 0.28upper gastrointestinal cancer humanFrequency % above threshold: 2.5      
SELDI-IMAC30 (Cu2+)26181.29 0.25upper gastrointestinal cancer humanFrequency % above threshold: 0.5      
SELDI-IMAC30 (Cu2+)26382.55 0.2upper gastrointestinal cancer humanFrequency % above threshold: 3.5      
SELDI-IMAC30 (Cu2+)26524.88 0.18upper gastrointestinal cancer humanFrequency % above threshold: 1      
SELDI-IMAC30 (Cu2+)26612.82 0.17upper gastrointestinal cancer humanFrequency % above threshold: 2      
SELDI-IMAC30 (Cu2+)26674.89 0.15upper gastrointestinal cancer humanFrequency % above threshold: 1.5      
SELDI-IMAC30 (Cu2+)26776.13 0.14upper gastrointestinal cancer humanFrequency % above threshold: 4.5      
SELDI-IMAC30 (Cu2+)27052.76 0.1upper gastrointestinal cancer humanFrequency % above threshold: 1.5      
SELDI-IMAC30 (Cu2+)27645.99 0.1upper gastrointestinal cancer humanFrequency % above threshold: 4      
SELDI-IMAC30 (Cu2+)27962.61 0.13upper gastrointestinal cancer humanFrequency % above threshold: 4.5      
SELDI-IMAC30 (Cu2+)28031.95 0.13upper gastrointestinal cancer humanFrequency % above threshold: 4      
SELDI-IMAC30 (Cu2+)28371.82 0.18upper gastrointestinal cancer humanFrequency % above threshold: 37.6      
SELDI-IMAC30 (Cu2+)28721.51 0.15upper gastrointestinal cancer humanFrequency % above threshold: 3      
SELDI-IMAC30 (Cu2+)28931.89 0.15upper gastrointestinal cancer humanFrequency % above threshold: 15.4      
SELDI-IMAC30 (Cu2+)29166.09 0.15upper gastrointestinal cancer humanFrequency % above threshold: 6.9      
SELDI-IMAC30 (Cu2+)29275.35 0.15upper gastrointestinal cancer humanFrequency % above threshold: 4      
SELDI-IMAC30 (Cu2+)29407.11 0.16upper gastrointestinal cancer humanFrequency % above threshold: 8.9      
SELDI-IMAC30 (Cu2+)29710.68 0.18upper gastrointestinal cancer humanFrequency % above threshold: 26.7      
SELDI-IMAC30 (Cu2+)29975.12 0.15upper gastrointestinal cancer humanFrequency % above threshold: 6.9      
SELDI-IMAC30 (Cu2+)30135.29 0.15upper gastrointestinal cancer humanFrequency % above threshold: 2.5      
SELDI-IMAC30 (Cu2+)30313.76 0.15upper gastrointestinal cancer humanFrequency % above threshold: 8.4      
SELDI-IMAC30 (Cu2+)30462.19 0.15upper gastrointestinal cancer humanFrequency % above threshold: 4.5      
SELDI-IMAC30 (Cu2+)30686.41 0.15upper gastrointestinal cancer humanFrequency % above threshold: 7.4      
SELDI-IMAC30 (Cu2+)31108.91 0.2upper gastrointestinal cancer humanFrequency % above threshold: 52.5      
SELDI-IMAC30 (Cu2+)31474.07 0.16upper gastrointestinal cancer humanFrequency % above threshold: 17.3      
SELDI-IMAC30 (Cu2+)31790.85 0.15upper gastrointestinal cancer humanFrequency % above threshold: 13.9      
SELDI-IMAC30 (Cu2+)31999.59 0.12upper gastrointestinal cancer humanFrequency % above threshold: 5.5      
SELDI-IMAC30 (Cu2+)32291.1 0.11upper gastrointestinal cancer humanFrequency % above threshold: 4      
SELDI-IMAC30 (Cu2+)32584.3 0.1upper gastrointestinal cancer humanFrequency % above threshold: 11.4      
SELDI-IMAC30 (Cu2+)32769.37 0.09upper gastrointestinal cancer humanFrequency % above threshold: 3      
SELDI-IMAC30 (Cu2+)32913.38 0.08upper gastrointestinal cancer humanFrequency % above threshold: 4.5      
SELDI-IMAC30 (Cu2+)33198.45 0.1upper gastrointestinal cancer humanFrequency % above threshold: 25.3      
SELDI-IMAC30 (Cu2+)33485.6 0.1upper gastrointestinal cancer humanFrequency % above threshold: 6.9      
SELDI-IMAC30 (Cu2+)33880.59 0.11upper gastrointestinal cancer humanFrequency % above threshold: 31.7      
SELDI-IMAC30 (Cu2+)34257.41 0.09upper gastrointestinal cancer humanFrequency % above threshold: 8.9      
SELDI-IMAC30 (Cu2+)34524.82 0.1upper gastrointestinal cancer humanFrequency % above threshold: 22.3      
SELDI-IMAC30 (Cu2+)34776.37 0.09upper gastrointestinal cancer humanFrequency % above threshold: 10.9      
SELDI-IMAC30 (Cu2+)34993.27 0.09upper gastrointestinal cancer humanFrequency % above threshold: 10.4      
SELDI-IMAC30 (Cu2+)35183.94 0.09upper gastrointestinal cancer humanFrequency % above threshold: 5      
SELDI-IMAC30 (Cu2+)35371.92 0.1upper gastrointestinal cancer humanFrequency % above threshold: 19.3      
SELDI-IMAC30 (Cu2+)35625.65 0.09upper gastrointestinal cancer humanFrequency % above threshold: 13.4      
SELDI-IMAC30 (Cu2+)35819.26 0.09upper gastrointestinal cancer humanFrequency % above threshold: 4.5      
SELDI-IMAC30 (Cu2+)36010.69 0.09upper gastrointestinal cancer humanFrequency % above threshold: 4.5      
SELDI-IMAC30 (Cu2+)36149.42 0.1upper gastrointestinal cancer humanFrequency % above threshold: 5      
SELDI-IMAC30 (Cu2+)36431.39 0.1upper gastrointestinal cancer humanFrequency % above threshold: 4.5      
SELDI-IMAC30 (Cu2+)36550.73 0.11upper gastrointestinal cancer humanFrequency % above threshold: 2.5      
SELDI-IMAC30 (Cu2+)36713.4 0.11upper gastrointestinal cancer humanFrequency % above threshold: 3.5      
SELDI-IMAC30 (Cu2+)37039.27 0.15upper gastrointestinal cancer humanFrequency % above threshold: 31.7      
SELDI-IMAC30 (Cu2+)37480.42 0.14upper gastrointestinal cancer humanFrequency % above threshold: 39.1      
SELDI-IMAC30 (Cu2+)37848.41 0.13upper gastrointestinal cancer humanFrequency % above threshold: 6.9      
SELDI-IMAC30 (Cu2+)38123.31 0.13upper gastrointestinal cancer humanFrequency % above threshold: 24.8      
SELDI-IMAC30 (Cu2+)38567.14 0.13upper gastrointestinal cancer humanFrequency % above threshold: 22.8      
SELDI-IMAC30 (Cu2+)38940.34 0.11upper gastrointestinal cancer humanFrequency % above threshold: 9.9      
SELDI-IMAC30 (Cu2+)39276.5 0.1upper gastrointestinal cancer humanFrequency % above threshold: 3.5      
SELDI-IMAC30 (Cu2+)39513.01 0.11upper gastrointestinal cancer humanFrequency % above threshold: 8.4      
SELDI-IMAC30 (Cu2+)40032.09 0.14upper gastrointestinal cancer humanFrequency % above threshold: 47      
SELDI-IMAC30 (Cu2+)40473.75 0.11upper gastrointestinal cancer humanFrequency % above threshold: 5.5      
SELDI-IMAC30 (Cu2+)40990.14 0.12upper gastrointestinal cancer humanFrequency % above threshold: 38.6      
SELDI-IMAC30 (Cu2+)41588.19 0.12upper gastrointestinal cancer humanFrequency % above threshold: 9.4      
SELDI-IMAC30 (Cu2+)41873.22 0.13upper gastrointestinal cancer humanFrequency % above threshold: 12.4      
SELDI-IMAC30 (Cu2+)42160.58 0.14upper gastrointestinal cancer humanFrequency % above threshold: 15.8      
SELDI-IMAC30 (Cu2+)42726.27 0.18upper gastrointestinal cancer humanFrequency % above threshold: 72.3      
SELDI-IMAC30 (Cu2+)43610.58 0.14upper gastrointestinal cancer humanFrequency % above threshold: 45.1      
SELDI-IMAC30 (Cu2+)44155.68 0.09upper gastrointestinal cancer humanFrequency % above threshold: 5.9      
SELDI-IMAC30 (Cu2+)44325.94 0.08upper gastrointestinal cancer humanFrequency % above threshold: 5.9      
SELDI-IMAC30 (Cu2+)44539.38 0.08upper gastrointestinal cancer humanFrequency % above threshold: 3.5      
SELDI-IMAC30 (Cu2+)44705.64 0.08upper gastrointestinal cancer humanFrequency % above threshold: 8.9      
SELDI-IMAC30 (Cu2+)44904.48 0.07upper gastrointestinal cancer humanFrequency % above threshold: 5      
SELDI-IMAC30 (Cu2+)45041.97 0.07upper gastrointestinal cancer humanFrequency % above threshold: 5      
SELDI-IMAC30 (Cu2+)45179.67 0.06upper gastrointestinal cancer humanFrequency % above threshold: 5      
SELDI-IMAC30 (Cu2+)45306.29 0.07upper gastrointestinal cancer humanFrequency % above threshold: 4.5      
SELDI-IMAC30 (Cu2+)45541.89 0.07upper gastrointestinal cancer humanFrequency % above threshold: 17.8      
SELDI-IMAC30 (Cu2+)45898.31 0.07upper gastrointestinal cancer humanFrequency % above threshold: 14.4      
SELDI-IMAC30 (Cu2+)46371.81 0.08upper gastrointestinal cancer humanFrequency % above threshold: 35.6      
SELDI-IMAC30 (Cu2+)47152.23 0.09upper gastrointestinal cancer humanFrequency % above threshold: 33.2      
SELDI-IMAC30 (Cu2+)47655.47 0.1upper gastrointestinal cancer humanFrequency % above threshold: 9.9      
SELDI-IMAC30 (Cu2+)47972.67 0.12upper gastrointestinal cancer humanFrequency % above threshold: 11.4      
SELDI-IMAC30 (Cu2+)48523.1 0.17upper gastrointestinal cancer humanFrequency % above threshold: 39.1      
SELDI-IMAC30 (Cu2+)49113.54 0.2upper gastrointestinal cancer humanFrequency % above threshold: 30.2      
SELDI-IMAC30 (Cu2+)49593.4 0.23upper gastrointestinal cancer humanFrequency % above threshold: 37.1      
SELDI-IMAC30 (Cu2+)50243.53 0.22upper gastrointestinal cancer humanFrequency % above threshold: 39.1      
SELDI-IMAC30 (Cu2+)50731.26 0.18upper gastrointestinal cancer humanFrequency % above threshold: 3.5      
SELDI-IMAC30 (Cu2+)51116.03 0.17upper gastrointestinal cancer humanFrequency % above threshold: 40.1      
SELDI-IMAC30 (Cu2+)51640.05 0.14upper gastrointestinal cancer humanFrequency % above threshold: 14.9      
SELDI-IMAC30 (Cu2+)52048.28 0.11upper gastrointestinal cancer humanFrequency % above threshold: 15.8      
SELDI-IMAC30 (Cu2+)52321.22 0.1upper gastrointestinal cancer humanFrequency % above threshold: 7.9      
SELDI-IMAC30 (Cu2+)52477.88 0.09upper gastrointestinal cancer humanFrequency % above threshold: 7.4      
SELDI-IMAC30 (Cu2+)52714.32 0.08upper gastrointestinal cancer humanFrequency % above threshold: 10.9      
SELDI-IMAC30 (Cu2+)53088.54 0.08upper gastrointestinal cancer humanFrequency % above threshold: 28.2      
SELDI-IMAC30 (Cu2+)53709.59 0.08upper gastrointestinal cancer humanFrequency % above threshold: 57.9      
SELDI-IMAC30 (Cu2+)54283.52 0.06upper gastrointestinal cancer humanFrequency % above threshold: 14.4      
SELDI-IMAC30 (Cu2+)54534.05 0.06upper gastrointestinal cancer humanFrequency % above threshold: 9.9      
SELDI-IMAC30 (Cu2+)54721.23 0.06upper gastrointestinal cancer humanFrequency % above threshold: 18.8      
SELDI-IMAC30 (Cu2+)54954.29 0.05upper gastrointestinal cancer humanFrequency % above threshold: 12.9      
SELDI-IMAC30 (Cu2+)55182.56 0.05upper gastrointestinal cancer humanFrequency % above threshold: 5      
SELDI-IMAC30 (Cu2+)55544.67 0.05upper gastrointestinal cancer humanFrequency % above threshold: 22.8      
SELDI-IMAC30 (Cu2+)56032.36 0.05upper gastrointestinal cancer humanFrequency % above threshold: 26.2      
SELDI-IMAC30 (Cu2+)56422.61 0.05upper gastrointestinal cancer humanFrequency % above threshold: 11.9      
SELDI-IMAC30 (Cu2+)56913.11 0.07upper gastrointestinal cancer humanFrequency % above threshold: 43.1      
SELDI-IMAC30 (Cu2+)57431.44 0.06upper gastrointestinal cancer humanFrequency % above threshold: 15.4      
SELDI-IMAC30 (Cu2+)57862.39 0.07upper gastrointestinal cancer humanFrequency % above threshold: 21.8      
SELDI-IMAC30 (Cu2+)58375 0.09upper gastrointestinal cancer humanFrequency % above threshold: 36.1      
SELDI-IMAC30 (Cu2+)58888.37 0.1upper gastrointestinal cancer humanFrequency % above threshold: 19.3      
SELDI-IMAC30 (Cu2+)59186.36 0.1upper gastrointestinal cancer humanFrequency % above threshold: 12.9      
SELDI-IMAC30 (Cu2+)59621.97 0.11upper gastrointestinal cancer humanFrequency % above threshold: 40.6      
SELDI-IMAC30 (Cu2+)60244.88 0.11upper gastrointestinal cancer humanFrequency % above threshold: 46.5      
SELDI-IMAC30 (Cu2+)60778.65 0.1upper gastrointestinal cancer humanFrequency % above threshold: 16.8      
SELDI-IMAC30 (Cu2+)61124.59 0.1upper gastrointestinal cancer humanFrequency % above threshold: 27.2      
SELDI-IMAC30 (Cu2+)61735.2 0.09upper gastrointestinal cancer humanFrequency % above threshold: 38.1      
SELDI-IMAC30 (Cu2+)62241.77 0.07upper gastrointestinal cancer humanFrequency % above threshold: 16.3      
SELDI-IMAC30 (Cu2+)62882.9 0.07upper gastrointestinal cancer humanFrequency % above threshold: 35.6      
SELDI-IMAC30 (Cu2+)63480.4 0.07upper gastrointestinal cancer humanFrequency % above threshold: 18.3      
SELDI-IMAC30 (Cu2+)64030.24 0.07upper gastrointestinal cancer humanFrequency % above threshold: 39.6      
SELDI-IMAC30 (Cu2+)64601.66 0.07upper gastrointestinal cancer humanFrequency % above threshold: 19.3      
SELDI-IMAC30 (Cu2+)64901.82 0.07upper gastrointestinal cancer humanFrequency % above threshold: 5.9      
SELDI-IMAC30 (Cu2+)65115.03 0.07upper gastrointestinal cancer humanFrequency % above threshold: 15.4      
SELDI-IMAC30 (Cu2+)65721.68 0.1upper gastrointestinal cancer humanFrequency % above threshold: 47.5      
SELDI-IMAC30 (Cu2+)66311.83 0.11upper gastrointestinal cancer humanFrequency % above threshold: 3.5      
SELDI-IMAC30 (Cu2+)66484.29 0.13upper gastrointestinal cancer humanFrequency % above threshold: 5.9      
SELDI-IMAC30 (Cu2+)66704.92 0.16upper gastrointestinal cancer humanFrequency % above threshold: 9.4      
SELDI-IMAC30 (Cu2+)67165.03 0.19upper gastrointestinal cancer humanFrequency % above threshold: 55      
SELDI-IMAC30 (Cu2+)67829.88 0.14upper gastrointestinal cancer humanFrequency % above threshold: 32.2      
SELDI-IMAC30 (Cu2+)68467.55 0.12upper gastrointestinal cancer humanFrequency % above threshold: 34.2      
SELDI-IMAC30 (Cu2+)69337.42 0.1upper gastrointestinal cancer humanFrequency % above threshold: 52      
SELDI-IMAC30 (Cu2+)70346.38 0.07upper gastrointestinal cancer humanFrequency % above threshold: 24.8      
SELDI-IMAC30 (Cu2+)70653.34 0.07upper gastrointestinal cancer humanFrequency % above threshold: 5.9      
SELDI-IMAC30 (Cu2+)71078.95 0.07upper gastrointestinal cancer humanFrequency % above threshold: 40.1      
SELDI-IMAC30 (Cu2+)71747.28 0.07upper gastrointestinal cancer humanFrequency % above threshold: 42.6      
SELDI-IMAC30 (Cu2+)72353.16 0.06upper gastrointestinal cancer humanFrequency % above threshold: 20.3      
SELDI-IMAC30 (Cu2+)72744.05 0.05upper gastrointestinal cancer humanFrequency % above threshold: 10.4      
SELDI-IMAC30 (Cu2+)73158.98 0.06upper gastrointestinal cancer humanFrequency % above threshold: 18.8      
SELDI-IMAC30 (Cu2+)73617 0.06upper gastrointestinal cancer humanFrequency % above threshold: 30.2      
SELDI-IMAC30 (Cu2+)74420.52 0.07upper gastrointestinal cancer humanFrequency % above threshold: 43.6      
SELDI-IMAC30 (Cu2+)75397.5 0.08upper gastrointestinal cancer humanFrequency % above threshold: 50      
SELDI-IMAC30 (Cu2+)76077.8 0.07upper gastrointestinal cancer humanFrequency % above threshold: 12.4      
SELDI-IMAC30 (Cu2+)76593.16 0.09upper gastrointestinal cancer humanFrequency % above threshold: 16.8      
SELDI-IMAC30 (Cu2+)76905.76 0.09upper gastrointestinal cancer humanFrequency % above threshold: 3.5      
SELDI-IMAC30 (Cu2+)77428.81 0.12upper gastrointestinal cancer humanFrequency % above threshold: 30.2      
SELDI-IMAC30 (Cu2+)78299.54 0.16upper gastrointestinal cancer humanFrequency % above threshold: 24.8      
SELDI-IMAC30 (Cu2+)78950.49 0.22upper gastrointestinal cancer humanFrequency % above threshold: 9.4      
SELDI-IMAC30 (Cu2+)79304.37 0.25upper gastrointestinal cancer humanFrequency % above threshold: 7.4      
SELDI-IMAC30 (Cu2+)79896.75 0.28upper gastrointestinal cancer humanFrequency % above threshold: 50.5      
SELDI-IMAC30 (Cu2+)80637.29 0.26upper gastrointestinal cancer humanFrequency % above threshold: 17.8      
SELDI-IMAC30 (Cu2+)81203.49 0.25upper gastrointestinal cancer humanFrequency % above threshold: 12.4      
SELDI-IMAC30 (Cu2+)81899.63 0.26upper gastrointestinal cancer humanFrequency % above threshold: 41.1      
SELDI-IMAC30 (Cu2+)82655.28 0.24upper gastrointestinal cancer humanFrequency % above threshold: 28.2      
SELDI-IMAC30 (Cu2+)83061.56 0.23upper gastrointestinal cancer humanFrequency % above threshold: 10.4      
SELDI-IMAC30 (Cu2+)83564.55 0.23upper gastrointestinal cancer humanFrequency % above threshold: 38.1      
SELDI-IMAC30 (Cu2+)84301.77 0.21upper gastrointestinal cancer humanFrequency % above threshold: 30.2      
SELDI-IMAC30 (Cu2+)85021.53 0.19upper gastrointestinal cancer humanFrequency % above threshold: 19.3      
SELDI-IMAC30 (Cu2+)86014.05 0.16upper gastrointestinal cancer humanFrequency % above threshold: 41.6      
SELDI-IMAC30 (Cu2+)86850.9 0.13upper gastrointestinal cancer humanFrequency % above threshold: 8.9      
SELDI-IMAC30 (Cu2+)87596.54 0.11upper gastrointestinal cancer humanFrequency % above threshold: 29.7      
SELDI-IMAC30 (Cu2+)88454 0.09upper gastrointestinal cancer humanFrequency % above threshold: 20.8      
SELDI-IMAC30 (Cu2+)89245.7 0.07upper gastrointestinal cancer humanFrequency % above threshold: 26.2      
SELDI-IMAC30 (Cu2+)89841.97 0.06upper gastrointestinal cancer humanFrequency % above threshold: 7.4      
SELDI-IMAC30 (Cu2+)90053.34 0.05upper gastrointestinal cancer humanFrequency % above threshold: 4      
SELDI-IMAC30 (Cu2+)90256.64 0.05upper gastrointestinal cancer humanFrequency % above threshold: 5.9      
SELDI-IMAC30 (Cu2+)90684.72 0.05upper gastrointestinal cancer humanFrequency % above threshold: 33.2      
SELDI-IMAC30 (Cu2+)91422.24 0.04upper gastrointestinal cancer humanFrequency % above threshold: 29.7      
SELDI-IMAC30 (Cu2+)92237.92 0.04upper gastrointestinal cancer humanFrequency % above threshold: 30.2      
SELDI-IMAC30 (Cu2+)93136.6 0.04upper gastrointestinal cancer humanFrequency % above threshold: 46      
SELDI-IMAC30 (Cu2+)93724.42 0.03upper gastrointestinal cancer humanFrequency % above threshold: 5      
SELDI-IMAC30 (Cu2+)94069.77 0.03upper gastrointestinal cancer humanFrequency % above threshold: 24.3      
SELDI-IMAC30 (Cu2+)94757.25 0.03upper gastrointestinal cancer humanFrequency % above threshold: 35.2      
SELDI-IMAC30 (Cu2+)95619.94 0.03upper gastrointestinal cancer humanFrequency % above threshold: 44.1      
SELDI-IMAC30 (Cu2+)96359.27 0.03upper gastrointestinal cancer humanFrequency % above threshold: 25.3      
SELDI-IMAC30 (Cu2+)97304.33 0.03upper gastrointestinal cancer humanFrequency % above threshold: 60.9      
SELDI-IMAC30 (Cu2+)98121.32 0.02upper gastrointestinal cancer humanFrequency % above threshold: 14.9      
SELDI-IMAC30 (Cu2+)98619.87 0.02upper gastrointestinal cancer humanFrequency % above threshold: 16.3      
SELDI-IMAC30 (Cu2+)99485.62 0.03upper gastrointestinal cancer humanFrequency % above threshold: 62.4      
SELDI-IMAC30 (Cu2+)100449.37 0.02upper gastrointestinal cancer humanFrequency % above threshold: 24.3      
SELDI-IMAC30 (Cu2+)100913.04 0.02upper gastrointestinal cancer humanFrequency % above threshold: 10.4      
SELDI-IMAC30 (Cu2+)101285.33 0.02upper gastrointestinal cancer humanFrequency % above threshold: 21.8      
SELDI-IMAC30 (Cu2+)101693.82 0.02upper gastrointestinal cancer humanFrequency % above threshold: 9.4      
SELDI-IMAC30 (Cu2+)102345.46 0.03upper gastrointestinal cancer humanFrequency % above threshold: 45.5      
SELDI-IMAC30 (Cu2+)103293.25 0.02upper gastrointestinal cancer humanFrequency % above threshold: 44.6      
SELDI-IMAC30 (Cu2+)104101.45 0.02upper gastrointestinal cancer humanFrequency % above threshold: 25.7      
SELDI-IMAC30 (Cu2+)104875.13 0.02upper gastrointestinal cancer humanFrequency % above threshold: 29.2      
SELDI-IMAC30 (Cu2+)105521.3 0.02upper gastrointestinal cancer humanFrequency % above threshold: 11.9      
SELDI-IMAC30 (Cu2+)105889.72 0.02upper gastrointestinal cancer humanFrequency % above threshold: 5.5      
SELDI-IMAC30 (Cu2+)106652.18 0.02upper gastrointestinal cancer humanFrequency % above threshold: 46      
SELDI-IMAC30 (Cu2+)107578.64 0.02upper gastrointestinal cancer humanFrequency % above threshold: 30.2      
SELDI-IMAC30 (Cu2+)108270.32 0.02upper gastrointestinal cancer humanFrequency % above threshold: 22.3      
SELDI-IMAC30 (Cu2+)109063.08 0.02upper gastrointestinal cancer humanFrequency % above threshold: 39.6      
SELDI-IMAC30 (Cu2+)110052.59 0.02upper gastrointestinal cancer humanFrequency % above threshold: 36.6      
SELDI-IMAC30 (Cu2+)111087.92 0.02upper gastrointestinal cancer humanFrequency % above threshold: 35.2      
SELDI-IMAC30 (Cu2+)112220.42 0.02upper gastrointestinal cancer humanFrequency % above threshold: 56.9      
SELDI-IMAC30 (Cu2+)113392.26 0.02upper gastrointestinal cancer humanFrequency % above threshold: 25.7      
SELDI-IMAC30 (Cu2+)114621.06 0.02upper gastrointestinal cancer humanFrequency % above threshold: 57.4      
SELDI-IMAC30 (Cu2+)115479.33 0.01upper gastrointestinal cancer humanFrequency % above threshold: 8.9      
SELDI-IMAC30 (Cu2+)116262.25 0.02upper gastrointestinal cancer humanFrequency % above threshold: 33.2      
SELDI-IMAC30 (Cu2+)116992.2 0.02upper gastrointestinal cancer humanFrequency % above threshold: 13.9      
SELDI-IMAC30 (Cu2+)117669.96 0.02upper gastrointestinal cancer humanFrequency % above threshold: 34.7      
SELDI-IMAC30 (Cu2+)119336.5 0.02upper gastrointestinal cancer humanFrequency % above threshold: 74.3      
SELDI-IMAC30 (Cu2+)120893.71 0.02upper gastrointestinal cancer humanFrequency % above threshold: 27.2      
SELDI-IMAC30 (Cu2+)121555.64 0.01upper gastrointestinal cancer humanFrequency % above threshold: 4.5      
SELDI-IMAC30 (Cu2+)122430.94 0.02upper gastrointestinal cancer humanFrequency % above threshold: 55      
SELDI-IMAC30 (Cu2+)123586.02 0.02upper gastrointestinal cancer humanFrequency % above threshold: 20.3      
SELDI-IMAC30 (Cu2+)124670.99 0.02upper gastrointestinal cancer humanFrequency % above threshold: 43.6      
SELDI-IMAC30 (Cu2+)126201.84 0.02upper gastrointestinal cancer humanFrequency % above threshold: 35.2      
SELDI-IMAC30 (Cu2+)127080.08 0.02upper gastrointestinal cancer humanFrequency % above threshold: 4.5      
SELDI-IMAC30 (Cu2+)127721.73 0.02upper gastrointestinal cancer humanFrequency % above threshold: 40.6      
SELDI-IMAC30 (Cu2+)128939.23 0.02upper gastrointestinal cancer humanFrequency % above threshold: 39.6      
SELDI-IMAC30 (Cu2+)130491.75 0.02upper gastrointestinal cancer humanFrequency % above threshold: 40.6      
SELDI-IMAC30 (Cu2+)131603.42 0.02upper gastrointestinal cancer humanFrequency % above threshold: 13.9      
SELDI-IMAC30 (Cu2+)132615.13 0.02upper gastrointestinal cancer humanFrequency % above threshold: 42.6      
SELDI-IMAC30 (Cu2+)134440.14 0.02upper gastrointestinal cancer humanFrequency % above threshold: 53.5      
SELDI-IMAC30 (Cu2+)136648.69 0.02upper gastrointestinal cancer humanFrequency % above threshold: 45.5      
SELDI-IMAC30 (Cu2+)138389.5 0.02upper gastrointestinal cancer humanFrequency % above threshold: 46      
SELDI-IMAC30 (Cu2+)140060.58 0.01upper gastrointestinal cancer humanFrequency % above threshold: 37.1      
SELDI-IMAC30 (Cu2+)142393.79 0.02upper gastrointestinal cancer humanFrequency % above threshold: 59.9      
SELDI-IMAC30 (Cu2+)144966.94 0.01upper gastrointestinal cancer humanFrequency % above threshold: 51.5      
SELDI-IMAC30 (Cu2+)147419.98 0.01upper gastrointestinal cancer humanFrequency % above threshold: 60.9      
SELDI-IMAC30 (Cu2+)149076.06 0upper gastrointestinal cancer humanFrequency % above threshold: 2      
SELDI-IMAC30 (Cu2+)1885  colorectal cancer humanA1467P02671 fibrinogen 18558005
SELDI-IMAC30 (Cu2+)6086  colorectal cancer human     18558005
SELDI-IMAC30 (Cu2+)11750  colorectal cancer humanA8636P01884 2-microglobulin 18558005
SELDI-IMAC30 (Cu2+)11960  colorectal cancer humanA8636P01884 2-microglobulin 18558005
SELDI-IMAC30 (Cu2+)39480  colorectal cancer human     18558005
SELDI-IMAC30 (Cu2+)53760  colorectal cancer human     18558005
SELDI-IMAC30 (Cu2+)2788.45 47.9healthy human A9934P81172 hepcidin-25 17272487
SELDI-IMAC30 (Cu2+)2788.45 31.6healthy human A9934P81172 hepcidin-25 17272487
SELDI-IMAC30 (Cu2+)3917.07  pediatric nephrotic syndrome humanRegulation in disease: up-regulatedA8636P01884 potential triple charged beta-2-microglobulin 16810512
SELDI-IMAC30 (Cu2+)4155.53  pediatric nephrotic syndrome humanRegulation in disease: up-regulated     16810512
SELDI-IMAC30 (Cu2+)6329.68  pediatric nephrotic syndrome humanRegulation in disease: down-regulated     16810512
SELDI-IMAC30 (Cu2+)7036.96  pediatric nephrotic syndrome humanRegulation in disease: up-regulated     16810512
SELDI-IMAC30 (Cu2+)11117.4  pediatric nephrotic syndromeSteroid-resistant nephrotic syndrome (SRNS)humanRegulation in disease: up-regulatedA8636P01884 beta-2-microglobulin 16810512
SELDI-IMAC30 (Cu2+)4020  renal cell carcinomas (RCCs) humanRegulation in disease: differentially expressed in disease     18473487
SELDI-IMAC30 (Cu2+)4637  renal cell carcinomas (RCCs) humanRegulation in disease: differentially expressed in disease     18473487
SELDI-IMAC30 (Cu2+)5070  renal cell carcinomas (RCCs) humanRegulation in disease: differentially expressed in disease     18473487
SELDI-IMAC30 (Cu2+)5500  renal cell carcinomas (RCCs) humanRegulation in disease: differentially expressed in disease     18473487
SELDI-IMAC30 (Cu2+)5872 7.9renal transplant allograft rejection human     17035609
SELDI-IMAC30 (Cu2+)11311 8.3renal transplant allograft rejection human     17035609
SELDI-IMAC30 (Cu2+)11929 19.8renal transplant allograft rejection human     17035609
SELDI-IMAC30 (Cu2+)12727 13.2renal transplant allograft rejection human     17035609
SELDI-IMAC30 (Cu2+)13349 3.6renal transplant allograft rejection human     17035609
SELDI-IMAC30 (Cu2+)23482 4.8renal transplant allograft rejection human     17035609
SELDI-IMAC30 (Cu2+)3400  renal transplant patientsrenal rejection biomarker candidateshumanp-value: <0.0001     12724632
SELDI-IMAC30 (Cu2+)6500  renal transplant patientsrenal rejection biomarker candidateshumanp-value: <0.0001     12724632
SELDI-IMAC30 (Cu2+)6600  renal transplant patientsrenal rejection biomarker candidateshumanp-value: <0.0001     12724632
SELDI-IMAC30 (Cu2+)6700  renal transplant patientsrenal rejection biomarker candidateshumanp-value: <0.0001     12724632
SELDI-IMAC30 (Cu2+)7100  renal transplant patientsrenal rejection biomarker candidateshumanp-value: <0.0001     12724632
SELDI-IMAC30 (Cu2+)10000  renal transplant patientsrenal rejection biomarker candidateshumanp-value: <0.0001     12724632
SELDI-IMAC30 (Cu2+)13400  renal transplant patientsrenal rejection biomarker candidateshumanp-value: <0.0001     12724632
SELDI-IMAC30 (Cu2+)2326.5 0.01systemic lupus erythematosussystemic lupus erythematosushuman     17901988
SELDI-IMAC30 (Cu2+)22368.9 0.12systemic lupus erythematosussystemic lupus erythematosushuman     17901988
SELDI-IMAC30 (Cu2+)22401.9 0.12systemic lupus erythematosussystemic lupus erythematosushuman     17901988
SELDI-IMAC30 (Cu2+)23259.8 0.04systemic lupus erythematosussystemic lupus erythematosushuman     17901988
SELDI-IMAC30 (Cu2+)23583.6 0.04systemic lupus erythematosussystemic lupus erythematosushuman     17901988
SELDI-IMAC30 (Cu2+)44739.5 0.03systemic lupus erythematosussystemic lupus erythematosushuman     17901988
SELDI-IMAC30 (Cu2+)44839.2 0.03systemic lupus erythematosussystemic lupus erythematosushuman     17901988
SELDI-IMAC30 (Cu2+)56624.4 0.02systemic lupus erythematosussystemic lupus erythematosushuman     17901988
SELDI-IMAC30 (Cu2+)79270.6 0.01systemic lupus erythematosussystemic lupus erythematosushuman     17901988
SELDI-IMAC30 (Cu2+)79363.7 0.01systemic lupus erythematosussystemic lupus erythematosushuman     17901988
SELDI-IMAC30 (Cu2+)100258.5 0systemic lupus erythematosussystemic lupus erythematosushuman     17901988
SELDI-IMAC30 (Cu2+)100547.6 0systemic lupus erythematosussystemic lupus erythematosushuman     17901988
SELDI-IMAC30 (Cu2+)133195.1 0.01systemic lupus erythematosussystemic lupus erythematosushuman     17901988
SELDI-IMAC30 (Cu2+)133366.4 0.01systemic lupus erythematosussystemic lupus erythematosushuman     17901988

Compile date 12-23-2014© PADB initiative